Fulcrum Therapeutics Inc. (NASDAQ:FULC) Q2 2020 Results Conference Call August 11, 2020 8:00 AM ET Company Participants Christi Waarich - Director, Corporate Communications & IR Robert Gould - CEO, President & Director Diego Cadavid - SVP of Clinical Development Owen Wallace - Chief Scientific Officer Bryan Stuart - Chief Operating Officer Conference Call Participants Joseph Schwartz - SVB Leerink Dae Gon Ha - BTIG Tazeen Ahmad - Bank of America Ted Tenthoff - Piper Sandler Matthew Harrison - Morgan Stanley ...